Skip to content
2000
Volume 22, Issue 2
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417

Abstract

Introduction

Type 2 diabetes (T2D) is a prevalent metabolic disorder linked to chronic inflammation and endothelial dysfunction, which contributes to the development of microvascular complications (MVCs) such as diabetic retinopathy (DR) and diabetic neuropathy (DN). Genetic factors, including variations in the ABO gene, may influence these complications. This study aimed to investigate the association between the ABO rs2073823 polymorphism and the risk of MVCs in patients with T2D, as well as its impact on inflammatory biomarkers, endothelial markers, and lipid profiles.

Materials and Methods

We conducted an exploratory study involving 96 T2D Iraqi patients (Asian Arabic), examining the distribution of the ABO rs2073823 polymorphism and its correlation with MVCs. We assessed levels of inflammatory markers (TNF-α, IL-6, sE-selectin, sP-selectin), glycemic markers, renal function biomarkers, and lipid profiles. Adjustment was made for confounding factors including age, gender, body mass index, duration of diabetes, and hypertension.

Results

Among the participants, 75% had MVCs, including DR (42%) and DN (65%). The ABO rs2073823 “A/A” genotype was associated with a reduced risk of MVCs under co-dominant (OR=0.16, =0.045) and recessive models (OR=0.14, =0.031). This protective effect remained significant after adjusting for confounding factors (OR=0.11, =0.022). The “A/A” genotype was also linked to lower levels of total cholesterol, LDL-cholesterol, triglycerides, and sP-selectin. Patients with MVCs exhibited significantly higher levels of TNF-α, IL-6, and sP-selectin.

Conclusion

The ABO rs2073823 polymorphism, particularly the “A/A” genotype, is associated with a decreased risk of MVCs in T2D patients and influences lipid metabolism and inflammatory markers. These findings suggest a genetic basis for the susceptibility to MVCs and highlight the role of the ABO gene in modulating inflammation and endothelial function in T2D. Further research is needed to validate these associations and explore potential therapeutic implications.

This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cdr/10.2174/0115733998341750241208055924
2025-01-16
2026-02-26
Loading full text...

Full text loading...

/deliver/fulltext/cdr/22/2/CDR-22-2-04.html?itemId=/content/journals/cdr/10.2174/0115733998341750241208055924&mimeType=html&fmt=ahah

References

  1. SunH. SaeediP. KarurangaS. PinkepankM. OgurtsovaK. DuncanB.B. SteinC. BasitA. ChanJ.C.N. MbanyaJ.C. PavkovM.E. RamachandaranA. WildS.H. JamesS. HermanW.H. ZhangP. BommerC. KuoS. BoykoE.J. MaglianoD.J. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.Diabetes Res. Clin. Pract.202218310911910.1016/j.diabres.2021.10911934879977
    [Google Scholar]
  2. Galicia-GarciaU. Benito-VicenteA. JebariS. Larrea-SebalA. SiddiqiH. UribeK.B. OstolazaH. MartínC. Pathophysiology of type 2 diabetes mellitus.Int. J. Mol. Sci.20202117627510.3390/ijms2117627532872570
    [Google Scholar]
  3. OkdahlT. WegebergA.M. PociotF. BrockB. StørlingJ. BrockC. Low-grade inflammation in type 2 diabetes: A cross-sectional study from a Danish diabetes outpatient clinic.BMJ Open20221212e06218810.1136/bmjopen‑2022‑06218836517105
    [Google Scholar]
  4. WangX. BaoW. LiuJ. OuYangY.Y. WangD. RongS. XiaoX. ShanZ.L. ZhangY. YaoP. LiuL.G. Inflammatory markers and risk of type 2 diabetes: A systematic review and meta-analysis.Diabetes Care201336116617510.2337/dc12‑070223264288
    [Google Scholar]
  5. CominaciniL. Fratta PasiniA. GarbinU. DavoliA. De SantisA. CampagnolaM. RigoniA. ZentiM.G. MoghettiP. Lo CascioV. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: Relation to metabolic control.Diabetologia19953891122112410.1007/BF004021858591829
    [Google Scholar]
  6. KoppH.P. HopmeierP. SchernthanerG. Concentrations of circulating P-Selectin are increased in patients with newly diagnosed insulin-dependent diabetes mellitus.Exp. Clin. Endocrinol. Diabetes19981061414410.1055/s‑0029‑12119489516058
    [Google Scholar]
  7. PaneniF. BeckmanJ.A. CreagerM.A. CosentinoF. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I.Eur. Heart J.201334312436244310.1093/eurheartj/eht14923641007
    [Google Scholar]
  8. CrastoW. PatelV. DaviesM.J. KhuntiK. Prevention of microvascular complications of diabetes.Endocrinol. Metab. Clin. North Am.202150343145510.1016/j.ecl.2021.05.00534399955
    [Google Scholar]
  9. GirachA. VignatiL. Diabetic microvascular complications—can the presence of one predict the development of another?J. Diabetes Complications200620422823710.1016/j.jdiacomp.2006.03.00116798474
    [Google Scholar]
  10. NguyenD.V. ShawL.C. GrantM.B. Inflammation in the pathogenesis of microvascular complications in diabetes.Front. Endocrinol.2012317010.3389/fendo.2012.0017023267348
    [Google Scholar]
  11. KarimiM.A. VaeziA. AnsariA. ArchinI. DadgarK. RasouliA. GhannadikhoshP. AlishiriG. TizroN. GhareiF. ImanparvarS. SalehiS. MazhariS.A. EtemadiM.H. AlipourM. DeraviN. NaziriM. Lipid variability and risk of microvascular complications in patients with diabetes: A systematic review and meta-analysis.BMC Endocr. Disord.2024241410.1186/s12902‑023‑01526‑938167035
    [Google Scholar]
  12. MansourA. MousaM. AbdelmannanD. TayG. HassounA. AlsafarH. Microvascular and macrovascular complications of type 2 diabetes mellitus: Exome wide association analyses.Front. Endocrinol. 202314114306710.3389/fendo.2023.114306737033211
    [Google Scholar]
  13. ImamuraM. MaedaS. Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine.J. Diabetes Investig.202415441042210.1111/jdi.1414938259175
    [Google Scholar]
  14. Ferguson-SmithM.A. AitkenD.A. TurleauC. de GrouchyJ. Localisation of the human ABO: Np-1: AK-1 linkage group by regional assignment of AK-1 to 9q34.Hum. Genet.1976341354310.1007/BF00284432184030
    [Google Scholar]
  15. BennettE.P. SteffensenR. ClausenH. WeghuisD.O. VankesselA.G. Genomic cloning of the human histo-blood group ABO locus.Biochem. Biophys. Res. Commun.1995206131832510.1006/bbrc.1995.10447598760
    [Google Scholar]
  16. YamamotoF. A historical overview of advances in molecular genetic/genomic studies of the ABO blood group system.Glycoconj. J.202239220721810.1007/s10719‑021‑10028‑634757541
    [Google Scholar]
  17. ChesterM. OlssonM. The ABO blood group gene: A locus of considerable genetic diversity.Transfus. Med. Rev.200115317720010.1053/tmrv.2001.2459111471121
    [Google Scholar]
  18. LiY. LiuL. HuangY. ZhengH. LiL. Association of ABO polymorphisms and pancreatic cancer/ cardiocerebrovascular disease: A meta-analysis.BMC Med. Genet.20202114110.1186/s12881‑020‑0975‑832093636
    [Google Scholar]
  19. GassóP. MasS. ÁlvarezS. OrtizJ. SotocaJ.M. FrancinoA. CarneX. LafuenteA. A common variant of the ABO gene protects against hypertension in a Spanish population.Hypertens. Res.201235659259610.1038/hr.2011.21822258027
    [Google Scholar]
  20. WuK.C.H. HeQ. BennettA.N. LiJ. ChanK.H.K. Shared genetic mechanism between type 2 diabetes and COVID-19 using pathway-based association analysis.Front. Genet.202213106351910.3389/fgene.2022.106351936482905
    [Google Scholar]
  21. HöglundJ. KarlssonT. JohanssonT. EkW.E. JohanssonÅ. Characterization of the human ABO genotypes and their association to common inflammatory and cardiovascular diseases in the UK Biobank.Am. J. Hematol.202196111350136210.1002/ajh.2630734329492
    [Google Scholar]
  22. ArguinanoA.A.A. NdiayeN.C. MassonC. Visvikis-SiestS. Pleiotropy of ABO gene: Correlation of rs644234 with E-selectin and lipid levels.Clinical Chemistry and Laboratory Medicine (CCLM)201856574875410.1515/cclm‑2017‑034729373315
    [Google Scholar]
  23. GrattenJ. VisscherP.M. Genetic pleiotropy in complex traits and diseases: Implications for genomic medicine.Genome Med.2016817810.1186/s13073‑016‑0332‑x27435222
    [Google Scholar]
  24. QiL. CornelisM.C. KraftP. JensenM. van DamR.M. SunQ. GirmanC.J. LaurieC.C. MirelD.B. HunterD.J. RimmE. HuF.B. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes.Hum. Mol. Genet.20101991856186210.1093/hmg/ddq05720147318
    [Google Scholar]
  25. BarbalicM. DupuisJ. DehghanA. BisJ.C. HoogeveenR.C. SchnabelR.B. NambiV. BretlerM. SmithN.L. PetersA. LuC. TracyR.P. AleksicN. HeerigaJ. KeaneyJ.F.Jr RiceK. LipG.Y.H. VasanR.S. GlazerN.L. LarsonM.G. UitterlindenA.G. YamamotoJ. DurdaP. HarituniansT. PsatyB.M. BoerwinkleE. HofmanA. KoenigW. JennyN.S. WittemanJ.C. BallantyneC. BenjaminE.J. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels.Hum. Mol. Genet.20101991863187210.1093/hmg/ddq06120167578
    [Google Scholar]
  26. PatersonA.D. Lopes-VirellaM.F. WaggottD. BorightA.P. HosseiniS.M. CarterR.E. ShenE. MireaL. BharajB. SunL. BullS.B. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin.Arterioscler. Thromb. Vasc. Biol.200929111958196710.1161/ATVBAHA.109.19297119729612
    [Google Scholar]
  27. KarakasM. BaumertJ. KleberM.E. ThorandB. DallmeierD. SilbernagelG. GrammerT.B. RottbauerW. MeisingerC. IlligT. MärzW. KoenigW. A variant in the ABO gene explains the variation in soluble E-selectin levels-results from dense genotyping in two independent populations.PLoS One2012712e5144110.1371/journal.pone.005144123300549
    [Google Scholar]
  28. NiX. BaiC. NieC. QiL. LiuY. YuanH. ZhuX. SunL. ZhouQ. LiY. ZhenH. SuH. LiR. LanR. PangG. LvY. ZhangW. YangF. YaoY. ChenC. WangZ. GaoD. ZhangN. ZhangS. ZhangL. WuZ. HuC. ZengY. YangZ. Identification and replication of novel genetic variants of ABO gene to reduce the incidence of diseases and promote longevity by modulating lipid homeostasis.Aging20211322246552467410.18632/aging.20370034812738
    [Google Scholar]
  29. TengM.S. HsuL.A. WuS. ChouH.H. ChangC.J. SunY.Z. JuanS.H. KoY.L. Mediation analysis reveals a sex-dependent association between ABO gene variants and TG/HDL-C ratio that is suppressed by sE-selectin level.Atherosclerosis2013228240641210.1016/j.atherosclerosis.2013.03.03223623010
    [Google Scholar]
  30. Quevedo-MartínezJ.U. GarfiasY. JimenezJ. GarciaO. VenegasD. Bautista de LucioV.M. Pro-inflammatory cytokine profile is present in the serum of Mexican patients with different stages of diabetic retinopathy secondary to type 2 diabetes.BMJ Open Ophthalmol.202161e00071710.1136/bmjophth‑2021‑00071734263060
    [Google Scholar]
  31. GoldbergR.B. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications.J. Clin. Endocrinol. Metab.20099493171318210.1210/jc.2008‑253419509100
    [Google Scholar]
  32. StortiF. PulleyJ. KunerP. AbtM. LuhmannU.F.O. Circulating biomarkers of inflammation and endothelial activation in diabetic retinopathy.Transl. Vis. Sci. Technol.20211012810.1167/tvst.10.12.834614163
    [Google Scholar]
  33. SiddiquiK. GeorgeT.P. MujammamiM. IsnaniA. AlfaddaA.A. The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study.Front. Endocrinol. 202314107228810.3389/fendo.2023.107228836843591
    [Google Scholar]
  34. HongK.W. MoonS. KimY.J. KimY.K. KimD.J. KimC. KimS.S. KimB.J. Association between the ABO locus and hematological traits in Korean.BMC Genet.20121317810.1186/1471‑2156‑13‑7822963146
    [Google Scholar]
  35. ShahbaziS. MashayekhiA. FatahiN. MahdaviM.R. Association of ABO and colton blood group gene polymorphisms with hematological traits variation.Medicine20159448e214410.1097/MD.000000000000214426632894
    [Google Scholar]
  36. JeeD. HuangS. KangS. ParkS. Polygenetic-risk scores for a glaucoma risk interact with blood pressure, glucose control, and carbohydrate intake.Nutrients20201211328210.3390/nu1211328233114701
    [Google Scholar]
  37. JoB.S. ChoiS.S. Introns: The functional benefits of introns in genomes.Genomics Inform.201513411211810.5808/GI.2015.13.4.11226865841
    [Google Scholar]
  38. Adnan F Al-Azzawie Al-AzzawieA.F. Al-AssieA.H.A. Intronic SNPs and genetic diseases: A review.Int. J. Res. Appl. Sci. Biotechnol.20218226727410.31033/ijrasb.8.2.36
    [Google Scholar]
  39. ThomasA. AbelH.J. DiY. FayeL.L. JinJ. LiuJ. WuZ. PatersonA.D. Effect of linkage disequilibrium on the identification of functional variants.Genet. Epidemiol.201135S1Suppl. 1S115S11910.1002/gepi.2066022128051
    [Google Scholar]
/content/journals/cdr/10.2174/0115733998341750241208055924
Loading
/content/journals/cdr/10.2174/0115733998341750241208055924
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test